If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Tenet Healthcare (THC) . This company, which is in the Zacks Medical - Hospital industry, shows potential for another earnings beat.This hospital operator has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 17.14%.For the ...

公司背景 - Tenet Healthcare Corporation (NYSE: THC)总部位于达拉斯，是一家多元化的医疗服务公司[2] - Tenet Healthcare Corporation (NYSE: THC)经营着480多家日间手术中心和外科医院，以及61家急诊医院和专科医院[2] 业绩发布 - Tenet Healthcare Corporation (NYSE: THC)将于2024年2月8日发布2023年第四季度业绩[1]

财务数据和关键指标变化 - 公司在第三季度实现净营业收入51亿美元,合并调整后EBITDA为8.54亿美元,EBITDA利润率接近17% [10] - USPI业务在第三季度实现调整后EBITDA3.7亿美元,同比增长16% [11][41][42] - 医院业务在第三季度实现调整后EBITDA4.01亿美元 [16] - 公司合并的工资和福利成本占收入的比例为45.2%,较去年同期下降了120个基点 [44][45] - 医疗费用同比增加15%,但较上一季度保持相对平稳 [46][47] 各条业务线数据和关键指标变化 - USPI同店系统收入同比增长7.9%,手术量增长4.1%,每例收入增长3.7% [41] - 医院非COVID入院量同比增长4.5% [43] - 医院业务的患者疾病严重程度和收益水平保持较高 [16][47] 各个市场数据和关键指标变化 - 公司未具体披露各个市场的数据和指标变化 [无] 公司战略和发展方向及行业竞争 - 公司继续专注于提供高级别服务,在医院和USPI业务中均有相关投资和布局 [17][18][29] - 公司在人员招聘和留存方面取得进展,大幅降低了临时合同护士的使用 [19][20][21] - 公司对GLP-1类药物的影响持谨慎态度,认为其不会改变公司向更高级别服务转型的战略 [26][27][28][29][30] - 公司在USPI业务方面持续扩张,包括新增6家中心、30个在建中心以及丰富的并购管线 [12][13][14][15] 管理层对经营环境和未来前景的评论 - 管理层对第四季度的表现持谨慎态度,希望看到一个没有COVID影响的正常季度 [79][80][81][82][83][84] - 管理层对2024年的前景持乐观态度,预计将实现收益增长,抵消约1亿美元的一次性因素 [56][57][58][59][60][61] 问答环节重要的提问和回答 问题1 **Josh Raskin提问** 询问USPI业务增长放缓的原因,以及对2024年同店收入增长的预期 [67][68] **Saum Sutaria回答** USPI业务增长仍保持高水平,且公司看好未来的发展前景 [73][74][75] 问题2 **Stephen Baxter提问** 询问第四季度医院业务EBITDA的环比变化以及公司对第四季度的谨慎态度 [77][78] **Saum Sutaria和Daniel Cancelmi回答** 公司对第四季度保持谨慎,主要是考虑到可能出现的COVID影响,但目前尚未看到明显迹象 [79][80][81][82][83][84][85] 问题3 **Whit Mayo提问** 询问USPI新增103项服务项目的具体情况 [88][89] **Saum Sutaria回答** 新增服务项目主要集中在高级别的骨科服务,以满足患者需求 [89][90]

Cautionary Statements NON-GAAP FINANCIAL INFORMATION Conifer • 4.1% case volume growth FY 2023 Outlook - Consolidated Adjusted EBITDA raised for the third time this year to a range of $3.365 billion to $3.465 billion 4 Note: 2023E is based on mid-point of Outlook range as of October 30, 2023. Reconciliations of these non-GAAP measures to the most comparable GAAP measures and management's reasoning for using these non-GAAP financial measures are included in our earnings press releases dated October 30, 2023, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 OR Form 10-Q TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No.) 14201 Dallas Parkway Dallas, TX 75254 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant's ...

Tenet Healthcare Corporation (NYSE:THC) Q2 2023 Earnings Conference Call July 31, 2023 5:00 PM ET Company Participants Will McDowell - VP, IR Saum Sutaria - CEO Daniel Cancelmi - CFO Conference Call Participants Will McMahon - Barclays Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Whit Mayo - Leerink Partners Andrew Mok - UBS Jason Cassorla - Citi Operator I'll now turn the call over to your host, Mr. Will McDowell, Vice President ...

业绩总结 - 公司2023年第二季度调整后的EBITDA为8.43亿美元，高于展望范围的上限[4] - 公司2023年财务展望中，调整后的EBITDA预期为33.1亿至34.6亿美元，年增长率在11.0%至16.5%之间[5] - 公司2023年USPI的调整后EBITDA展望中点为3.39亿美元，年增长率为16.5%[8] 用户数据 - USPI在2015-2022年间实现了5.3%的同设施系统范围内收入复合年增长率[10] - USPI的2022年病例组合中，胃肠病学占34%，肌肉骨骼科占36%[11] - USPI自2017年以来收购和新开设的设施数量达到479个，实现了投资资本的显著回报[12] 未来展望 - 公司计划每年在ASC平台投资2.5亿美元，继续投资技术、机器人技术和手术医院扩张，重点放在高病情服务上[15] - 公司预计2023年第三季度净收入可供普通股股东使用为7千5百万至1亿2千万美元，调整后净收入为5亿5千万至6亿4千万美元[22] - 公司预计2023年第三季度调整后每股稀释收益为0.94至1.28美元，全年为5.18至6.03美元[24] 市场扩张和并购 - 公司在2023年第二季度回购了价值4千6百万美元的普通股，自计划启动以来已回购了约7百4十万股，总价值3亿4千万美元[14] - 公司使用新发行的13.5亿美元到2031年到期的优先担保票据偿还了到2024年到期的13.45亿美元的优先担保票据[14] 其他新策略和有价值的信息 - 公司的债务到期情况显示，直到2026年没有重大到期债务[16] - 公司的调整后净收入从持续运营中可供普通股股东使用为1.54亿美元，调整后每股稀释收益为1.44美元[19] - 公司的调整后EBITDA为8.43亿美元，占净营业收入的比例为16.6%[20]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employ ...

Will McDowell - Vice President, Investor Relations Saum Sutaria - Chief Executive Officer Daniel Cancelmi - Chief Financial Officer Tenet Healthcare Corporation (NYSE:THC) Q1 2023 Earnings Conference Call April 25, 2023 10:00 AM ET Conference Call Participants Good morning, and welcome to the Tenet Healthcare First quarter 2023 Earnings Conference Call. After the speakerÂ's remarks, there will be a question-and-answer session for industry analysts. [Operator Instructions] Will McDowell Tenet senior manageme ...